文献速递精神分裂症与精神病性障碍儿童青少年精神

以遗传学为先导理解孤独症与精神分裂症谱系障碍:22q11.2缺失综合征

A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome.
PubMed 文献 · Mol Psychiatry · 2022-10-03

本文综述了22q11.2缺失综合征(22q11DS)作为遗传学先导模型,用于理解孤独症谱系障碍(ASD)和精神分裂症谱系障碍(SSD)的研究。文章围绕三个问题展开:如何将描述性诊断分类与高外显率遗传风险因素统一、从共享遗传基础的ASD或SSD个体中能学到什么、以及如何解释同一致病变异下神经精神表型的可变外显率和多效性。综述总结了临床和临床前研究结果,并讨论了遗传、环境和随机因素对表型表达的影响及未来研究方向。

要点

  • 22q11DS是研究ASD和SSD遗传基础的重要模型,具有较长研究历史。
  • 该模型有助于阐明特定基因型-表型关联及可变外显率和多效性机制。
  • 动物和体外研究可帮助揭示影响神经精神表型表达的因素。

核心结论

  • 22q11DS作为遗传学先导模型,可帮助理解ASD和SSD的神经发育机制及可变外显率和多效性。

研究设计与样本

  • 本文为综述,聚焦22q11.2缺失综合征的临床和临床前研究。

主要发现

  • 22q11DS是已知罕见致病变异中较常见的一种,且研究历史相对较长。
  • 该模型允许阐明特定基因型-表型关联,并在已知遗传基础上前瞻性研究ASD或SSD等行为定义分类。
  • 遗传、环境和随机因素可能影响22q11DS中神经精神表型的表达。

临床怎么用

  • 22q11DS模型可帮助识别神经精神表型表达的影响因素,并可能为一般人群神经发育表达机制提供信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently, increasing numbers of rare pathogenic genetic variants have been identified that are associated with variably elevated risks of a range of neurodevelopmental outcomes, notably including Autism Spectrum Disorders (ASD), Schizophrenia Spectrum Disorders (SSD), and Intellectual Disability (ID). This review is organized along three main questions: First, how can we unify the exclusively descriptive basis of our current psychiatric diagnostic classification system with the recognition of an identifiable, highly penetrant genetic risk factor in an increasing proportion of patients with ASD or SSD? Second, what can be learned from studies of individuals with ASD or SSD who share a common genetic basis? And third, what accounts for the observed variable penetrance and pleiotropy of neuropsychiatric phenotypes in individuals with the same pathogenic variant? In this review, we focus on findings of clinical and preclinical studies of the 22q11.2 deletion syndrome (22q11DS). This particular variant is not only one of the most common among the increasing list of known rare pathogenic variants, but also one that benefits from a relatively long research history. Consequently, 22q11DS is an appealing model as it allows us to: (1) elucidate specific genotype-phenotype associations, (2) prospectively study behaviorally defined classifications, such as ASD or SSD, in the context of a known, well-characterized genetic basis, and (3) elucidate mechanisms underpinning variable penetrance and pleiotropy, phenomena with far-reaching ramifications for research and clinical practice. We discuss how findings from animal and in vitro studies relate to observations in human studies and can help elucidate factors, including genetic, environmental, and stochastic, that impact the expression of neuropsychiatric phenotypes in 22q11DS, and how this may inform mechanisms underlying neurodevelopmental expression in the general population. We conclude with research priorities for the field, which may pave the way for novel therapeutics.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fiksinski AM, Hoftman GD, Vorstman JAS, et al. A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome. Mol Psychiatry. 2022. PMID: 36192458. doi:10.1038/s41380-022-01783-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。